F05 - Harnessing AI in Diabetes Prevention and Management: Empowering DCESs to Lead the Way

Friday, August 8, 2025

10:30 AM – 11:15 AM MT

CE/CME Hours: .75 CE

Primary Presenter(s)

Clipper Young, PharmD, MPH, CDE, BC-ADM, BCGP, APh, FADCES (he/him/his)

Associate Professor and Clinical Pharmacist
Touro University California
Fairfield, California

Disclosure(s): Sanofi: Consultant / Advisory Board (Terminated, October 31, 2024)

Co-Presenter(s)

Diana Isaacs, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM (she/her/hers)

Endocrine Pharmacist
Cleveland Clinic
University Heights, Ohio

Disclosure(s): Abbott: Speakers' Bureau (Ongoing); Dexcom: Speakers' Bureau (Ongoing); Insulet: Speakers' Bureau (Ongoing); Lilly: Speakers' Bureau (Ongoing); Medtronic: Consultant / Advisory Board (Ongoing); Novo Nordisk: Speakers' Bureau (Ongoing); Sanofi: Speakers' Bureau (Ongoing); Sequel: Consultant / Advisory Board (Ongoing)

Diabetes care and education specialists need to be equipped with the knowledge and tools to lead AI integration in their practice. The session will start with how AI can improve processes and outcomes and go through a series of applications in primary, secondary, and tertiary prevention in diabetes with applications related to AI-driven risk stratification, personalized lifestyle interventions and screenings, and CGM analytics for therapy adjustments. Barriers to AI will be addressed, and patient case scenarios will be used to apply the knowledge.

Disclosure(s):

Clipper Young, PharmD, MPH, CDE, BC-ADM, BCGP, APh, FADCES: Sanofi: Consultant / Advisory Board (Terminated, October 31, 2024)

Diana Isaacs, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM: Abbott: Speakers' Bureau (Ongoing); Dexcom: Speakers' Bureau (Ongoing); Insulet: Speakers' Bureau (Ongoing); Lilly: Speakers' Bureau (Ongoing); Medtronic: Consultant / Advisory Board (Ongoing); Novo Nordisk: Speakers' Bureau (Ongoing); Sanofi: Speakers' Bureau (Ongoing); Sequel: Consultant / Advisory Board (Ongoing)